Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Hepatol. Apr 27, 2012; 4(4): 149-153
Published online Apr 27, 2012. doi: 10.4254/wjh.v4.i4.149
Table 1 Beat-to-beat, non invasive hemodynamic evaluation in healthy subjects
SBPDBPDICHRSVRCCESVICIdP/dT
Baseline117 ± 1365 ± 782 ± 868 ± 101252 ± 1440.111 ± 0.120.0412 ± 0.0092.81 ± 0.350.81 ± 0.14
Standing111 ± 1168 ± 1584 ± 1378 ± 11a1504 ± 301b-0.193 ± 0.223b0.0305 ± 0.009b2.34 ± 0.46a0.72 ± 0.17
Recovery121 ± 1667 ± 886 ± 1066 ± 10a1260 ± 139b0.040 ± 0.250.0424 ± 0.007a2.86 ± 0.32b0.82 ± 0.16
Table 2 Beat-to-beat, non invasive hemodynamic evaluation in cirrhotic patients
SBPDBPDICHRSVRCCESVICIdP/dT
Baseline112 ± 1653 ± 865 ± 1169 ± 9973 ± 1690.29 ± 0.130.051 ± 0.0083.57 ± 0.521.06 ± 0.23
Standing117 ± 1861 ± 9b71 ± 1079 ± 13a1150 ± 281a0.183 ± 0.17a0.042 ± 0.009b03.31 ± 0.631.01 ± 0.24
Recovery116 ± 2056 ± 1169 ± 1670 ± 10a1047 ± 1580.253 ± 0.120.0514 ± 0.001a3.32 ± 0.421.02 ± 0.21
Table 3 Comparison between healthy subjects and cirrhotic patients
SBPDBPDICHRSVRCCESVICIdP/dT
Baseline
HS vs CNS< 0.001< 0.001NS< 0.001< 0.0010.01< 0.001< 0.001
Standing
HS vs CNSNS0.02NS< 0.0010.020.01< 0.001< 0.001
Recovery
HS vs CNS< 0.01< 0.001NS< 0.001NS< 0.05< 0.010.02